Hemfosa is acquiring the remaining holding of 35 percent in the existing Gardermoen Campus Utvikling AS, GCU, which has been a joint venture with the property development company Aspelin Ramm Eiendom AS. Further development of the area will continue in cooperation with Aspelin Ramm as part of an unchanged joint venture structure.

Hemfosa has signed an agreement for the acquisition of Aspelin Ramm’s shareholding in GCU totaling 35 percent at a value of approximately MSEK 328. GCU owns two properties under construction – a specialist hospital that is fully leased to Landsforeningen for Hjerte og Lungesyke (LHL, Norwegian Heart and Lung Association) with a 25-year lease and a local medical center, which is also fully leased to the Municipality of Ullensaker with a 30-year lease, in addition to a number of other tenants in the health and personal care sector. Both properties are expected to be completed by February 1, 2018. The acquisition of the remaining holding is scheduled to be finalized on February 15, 2018 and the two properties will be consolidated.

The hospital is expected to have about 500 employees and some 30,000 patients per year. In addition to the specialist hospital and the local medical center, the area – Gardermoen Campus – will also comprise activities in the fields of research and education, rehabilitation, physical therapy, offices and retail, all gathered in one place.

“The construction work is proceeding entirely according to plan and we are very pleased that Hemfosa will now be the long-term owner of these modern health and personal care properties, which are both fully leased. This is a natural step and we look forward to a continued close collaboration with LHL, the Municipality of Ullensaker and the other tenants in the development of the properties and this exciting center of expertise. This is an expansive area in a prime location and we see that there is good potential for more development projects moving forward,” comments Jens Engwall, CEO of Hemfosa.

For further information, please contact: 

Jens Engwall, CEO, [email protected], mobile +46 70 690 65 50, office +46 8 448 04 80
Simon Venemyr Ottersland, COO Norway, [email protected], mobile + 47 917 95 216